A_randomized_trial_comparing_radiation_therapy_versus_concomitant_radiation_therapy_and_chemotherapy_in_carcinoma_of_the_thoracic_esophagus._From_September_1982_to_December_1985,_59_previously_untreated_patients_with_Stage_II_squamous_cell_carcinoma_of_the_thoracic_esophagus_were_randomly_assigned_to_receive_radiation_therapy_(RT)_alone_versus_the_concomitant_use_of_RT_and_chemotherapy_(CT)_with_5-fluorouracil_(5-FU),_mitomycin_C,_and_bleomycin_(RT_+_CT)._Thirty-one_patients_were_randomized_to_the_RT_regimen_and_28_to_the_RT_+_CT_regimen._The_complete_local_response_rate_was_58%_for_the_RT_group_and_75%_for_the_RT_+_CT_group_(P_=_0.77)._The_median_duration_of_response_was_8_months_for_both_groups._The_overall_5-year_survival_rates_were_6%_and_16%_(P_=_0.16)_for_the_RT_and_RT_+_CT_groups,_respectively._Acute_toxicities_were_more_pronounced_in_the_RT_+_CT_group._This_clinical_trial_did_not_detect_a_difference_in_outcome_with_combined-technique_therapy._This_result_must_be_interpreted_with_caution_because_of_the_small_number_of_patients_entered_in_this_trial._Confirmation_of_the_value_or_lack_of_value_for_combined_therapy_will_require_additional_larger_clinical_trials.